Summary by Futu AI
Moderna, Inc. officer Shannon Thyme is set to sell 122 shares of the company's common stock on 06/03/2024, with an aggregate market value of $17,167.82. The shares were acquired on 05/31/2024 as part of a restricted stock vesting and are considered compensation for Thyme's role at Moderna. This transaction follows a series of sales over the past three months, where a total of 2,140 shares were sold for gross proceeds of $301,931.42.